Last reviewed · How we verify
NCT06824220
Effect of High-Flow Tracheal Oxygen on EELI
NA trial testing High-Flow Tracheal Oxygen in Tracheostomized Patients in 11 participants. Participants enrolled and being followed up; not accepting new ones.
31 March 2025
Quick facts
| Lead sponsor | Argentinian Intensive Care Society |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 11 |
| Start date | 1 December 2024 |
| Primary completion | 31 March 2025 |
| Estimated completion | 31 March 2025 |
| Sites | 1 location across Argentina |
Drugs / interventions tested
- High-Flow Tracheal Oxygen
Conditions studied
- Tracheostomized Patients — all drugs for Tracheostomized Patients →
Sponsor
Argentinian Intensive Care Society
Who can join
18 and older, any sex, with Tracheostomized Patients. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this analytical experimental study is to evaluate whether high-flow tracheal oxygen therapy at flow rates above 60 L/min increases end-expiratory lung impedance in tracheostomized patients in the intensive care unit. The main question it aims to answer is whether high-flow tracheal oxygen therapy improves end-expiratory lung impedance in tracheostomized patients. This study will be conducted in the Intensive Care Unit of Sanatorio Parque in Rosario, Santa Fe, Argentina, between December 1, 2024, and March 31, 2025. The participant population consists of adult ICU patients (≥18 years old) who are tracheostomized, have undergone at least 10 days of mechanical ventilation, and can tolerate spontaneous breathing for at least 12 hours. By analyzing the effects of high-flow tracheal oxygen therapy on lung function, this study aims to generate valuable insights into its physiological impact, potentially influencing clinical management strategies for tracheostomized patients in intensive care settings.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06824220
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Argentinian Intensive Care Society trials
Trials by the same sponsor.
- NCT07017205 — Microaspiration and Endotracheal Tubes · NA · not yet recruiting
- NCT06837402 — Epidemiology of Non- Invasive Mechanical Ventilation in Argentina: a Multicenter Observational Study · enrolling by invitation
- NCT06674629 — Asymmetrical High Flow Nasal Cannula and End-Expiratory Lung Impedance · completed
- NCT06662201 — Association Between P0.1 and Extubation Failure in Adult Patients With Acute Hypoxemic Respiratory Failure. A Multicente · active not recruiting
- NCT06536972 — Dual-focus Survey with an Emphasis on Heated Humidification Systems · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06824220 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Argentinian Intensive Care Society
- Last refreshed: 13 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06824220.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing